Thromb Haemost 1979; 42(03): 1009-1017
DOI: 10.1055/s-0038-1656991
Original Article
Schattauer GmbH Stuttgart

Factor-XII Congenital Deficiency. A New Family Study

J F Lucia
The Servicio Regional de Hematologia y Hemoterapia, Ciudad Sanitaria de la Seguridad Social, Zaragoza (Spain)
,
L Ercoreca
The Servicio Regional de Hematologia y Hemoterapia, Ciudad Sanitaria de la Seguridad Social, Zaragoza (Spain)
,
M Torres
The Servicio Regional de Hematologia y Hemoterapia, Ciudad Sanitaria de la Seguridad Social, Zaragoza (Spain)
,
M Giralt
The Servicio Regional de Hematologia y Hemoterapia, Ciudad Sanitaria de la Seguridad Social, Zaragoza (Spain)
,
A Raichs
The Servicio Regional de Hematologia y Hemoterapia, Ciudad Sanitaria de la Seguridad Social, Zaragoza (Spain)
› Author Affiliations
Further Information

Publication History

Received August 1978

Accepted 19 February 1979

Publication Date:
23 August 2018 (online)

Summary

This report describes two people in a family with Hageman trait (homozygotes) (Factor XII = 0.06%). In addition eight family members were studied to evaluate the inheritance of this congenital deficiency. A study of the Kallikrein-Kininogen system induced by the fragments of Factor XII was also carried out.

It is concluded that the inheritance is as described by Veltkamp and that the Kallikrein release from the prekallikreinogen (Fletcher factor) “in vitro” is related to the amount of Factor XII procoagulant protein.

 
  • References

  • 1 Abilgaard CF, Cornet JA, Alcalde V, Schulman I. 1963; Hageman factor deficiency in a child. Pediatrics 32: 280
  • 2 Aznar J, Mayans J, Aznar JA, Fernandez Pavon A, Calabuig R. 1973; Deficiencia de factor Hageman. A proposito de un caso Sangre 18 (03) 356
  • 3 Biggs R. 1972. Human Blood Coagulation, Haemostasis and Thrombosis. Blackwell Scientific Publications; Oxford:
  • 4 Blix S. 1961 Studies on the fibrinolytic system in the euglobulin fraction of the human plasma.
  • 5 Scandinavian Journal of Clinical and Labaratory Investigation. 13 suppl (Suppl. 58) 3
  • 6 Bok J, Veltkamp JJ, Loeliger A. 1965; Moderate factor XII deficiency. Thrombosis et diathesis Haemorrhagica 13: 8
  • 7 Brecher G, Cronkite EP. 1950; Morphology and enumeration of human blood platelets. Journal of Applied Physiology 3: 365
  • 8 Budtz-Olsen M. 1951. Clot retraction. Springfield I; 11 Charles C. Thomas:
  • 9 Colman RW. 1974; Formation of human plasma kinin. New England Journal of Medicine 291: 509
  • 10 Colman RW, Mason JW, Sherry S. 1969; The kallikreinogenkallikrein enzyme system of human plasma. Annals of Internal Medicine 71: 763
  • 11 Colman RW, Mattler L, Sherry S. 1969; Studies on the prekallikrem (Kallikreinogen)- kallikrein enzyme system of human plasma. II. Evidence relating the kaolinactivated arginine esterage to plasma kallikrein. Journal of Clinical Investigation 48: 23
  • 12 Duke W. 1910; The relation of blood platelets to hemorrhagic disease: Description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion. Journal of the American Medical Association 55: 1185
  • 13 Egeberg O. 1970; New families with Factor XII deficiency. Thromboses et diathesis Haemorrhagica 23: 441
  • 14 Haanen C, Hommes F, Morselt G. 1961; Some observations on the role of Hageman factor in blood coagulation. Thrombosises et diathesis Haemorrhagica 6: 261
  • 15 Hardisty RM, Margolis J. 1959; The role of Hageman factor in the initiation of blood coagulation. British Journal of Haematology 5: 203
  • 16 Hartert H. 1951; Die Thrombolastographie: Eine Methode zur physikalischen Analyse des Blutgerinnungsvorgangs. Zeitschrift fur die gesamte experimentelle Medizin 117: 189
  • 17 Jim RT S. 1957; A study of the plasma thrombin time. Journal of Laboratory and Clinical Medicine 50: 45
  • 18 Kasper DY E, Whissell Buechy. Aggeler PM. 1968; Hageman Factor (Factor XII) in an affected kindred and in normal adults. British Journal of Haematology 14: 543
  • 19 Lafuente Rodes R, Modolell Roig A, Sans Sabrafen J. 1975; Deficitcongenito de factor Hageman. A proposito de un caso. (Resumen). Sangre 20
  • 20 Lee L, White PD. 1913; A clinical study of the coagulation time of blood. American Journal of Science 145: 495
  • 21 Margolis I. 1957; Initiation of blood coagulation by glass and related surfaces. Journal of Physiology 137: 95
  • 22 Nagasawa S, Takahashi H, Koida M, Suzuki T, Schoenmakers J. 1968; Partial purification of human plasma Kallikreinogen, its activation by the Hageman factor. Biochemical and Biophysical Research Communications 32: 644
  • 23 Nossel HL. 1964. Contact Phase of Blood Coagulation. Blackwell Scientific Publications; Oxford:
  • 24 Owen Jr CA, Mann FD, Hurn MM, Stickney JM. 1955; Evaluation of disorders of blood coagulation in the clinical laboratory. American Journal of Clinical Pathology 25: 1417
  • 25 Proctor RS, Rapaport SI. 1961; The partial thromboplastin time with kaolin: a simple screening test for first stage plasma clotting factor deficiencies. American Journal of Clinical Pathology 36: 212
  • 26 Quick AJ. 1935; The prothrombin time in hamophilia and in obstructive jaundice. Journal of Biological Chemistry Abstracts 109: 73
  • 27 QUICK AJ, Favre-Gilly JE. 1949; The prothrombin consumption test: Its clinical and theoretic implications. Blood 4: 1261
  • 28 Ratnoff OD. 1954; A familial trait characterized by deficiency of a clot-promoting fraction of plasma. Journal of Laboratory and Clinical Medicine 44: 915
  • 29 Ratnoff OD, Margolius Jr A. 1957. Hageman factor and Hageman Trait. In Hemophilia and Hemophiloid Diseases. Brinkhous KM. (Ed.) University of North Carolina Press; Chapel Hill: p 124
  • 30 Ratnoff OD, Menzie CA B. 1951; A new method for the determination of fibrinogen in small samples of plasma. Journal of Laboratory and Clinical Medicine 37: 316
  • 31 Ratnoff OD, Rosenblum JM. 1958; Role of Hageman factor in the initiation of clotting by glass. American Journal of Medicine 25: 160
  • 32 Ratnoff OD, Steinberg AG. 1962; Further studies on the inheritance of Hageman trait. Journal of Laboratory and Clinical Medicine 59: 980
  • 33 Rutllant M. Lluch. 1972 Estudio de una familia afecta de la enfermedad de Hageman. XV Reunion anual de la Asociacion Espa�ola de Hematologia y Hemoterapia. Benidorm Octubre. 1972
  • 34 Saito H, Ratnoff OD, Donaldson VH, Haney G, Pensky J. 1974; Inhibition of the adsorption of Hageman factor (factor XII) to glass by normal human plasma. Journal of Laboratory and Clinical Medicine 84: 62
  • 35 Soria J, Soria C, Yver J, Samama M. 1969; L’interet de la reptilase dans l’etude de la fibrinoformation. Le temps de reptilase. Coagulation 2: 173
  • 36 Soulier JP, Prou-Wartelle O. 1960; New data on Hageman factor and plasma thromboplastin antecedent: the role of “contact” in the initial phase of blood coagulation. British Journal of Haematology 6: 88
  • 37 Soulier JP, Wartelle O, Menache D. 1959; Hageman trait and PTA deficiencie; the role of contact of blood with glass. British Journal of Haematology 5: 121
  • 38 Veltkamp JJ, Hemker HC, Loeliger EM. 1965; Detection of heterozygotes for factor VII, IX and XII deficiency. Thromboses et diathesis Haemorrhagica. suppl 17: 181